Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice

Journal of Cystic Fibrosis - Tập 10 - Trang 150-158 - 2011
M. Wouthuyzen-Bakker1, F.A.J.A. Bodewes1, H.J. Verkade1
1Pediatric Gastroenterology and Hepatology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, The Netherlands

Tài liệu tham khảo

Corey, 1988, A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto, J Clin Epidemiol, 41, 583, 10.1016/0895-4356(88)90063-7 Beker, 2001, Stature as a prognostic factor in cystic fibrosis survival, J Am Diet Assoc, 101, 438, 10.1016/S0002-8223(01)00113-4 Pencharz, 2000, Pathogenesis of malnutrition in cystic fibrosis, and its treatment, Clin Nutr, 19, 387, 10.1054/clnu.1999.0079 Littlewood, 2006, Diagnosis and treatment of intestinal malabsorption in cystic fibrosis, Pediatr Pulmonol, 41, 35, 10.1002/ppul.20286 FitzSimmons, 1997, High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis, N Engl J Med, 336, 1283, 10.1056/NEJM199705013361803 Taylor, 1999, Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis, Arch Dis Child, 80, 149, 10.1136/adc.80.2.149 Kalivianakis, 1999, Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids, Am J Clin Nutr, 69, 127, 10.1093/ajcn/69.1.127 Borowitz, 2005, Gastrointestinal outcomes and confounders in cystic fibrosis, J Pediatr Gastroenterol Nutr, 41, 273, 10.1097/01.mpg.0000178439.64675.8d Bijvelds, 2005, Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events, Am J Physiol Gastrointest Liver Physiol, 288, G646, 10.1152/ajpgi.00295.2004 Verkade, 2001, Biophysics of intestinal luminal lipids, 1 Zoppi, 1972, Exocrine pancreatic function in premature and full-term neonates, Pediatr Res, 6, 880, 10.1203/00006450-197212000-00005 Abrams, 1984, Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency, J Clin Investig, 73, 374, 10.1172/JCI111222 Minich, 1999, Bile diversion in rats leads to a decreased plasma concentration of linoleic acid which is not due to decreased net intestinal absorption of dietary linoleic acid, Biochim Biophys Acta, 1438, 111, 10.1016/S1388-1981(99)00033-5 Peretti, 2005, Mechanisms of lipid malabsorption in cystic fibrosis: the impact of essential fatty acids deficiency, Nutr Metab, 2, 11, 10.1186/1743-7075-2-11 Vassileva, 2000, The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice, J Fed Am Soc Exp Biol, 13, 2040 Levy, 2009, Localization, function and regulation of the two intestinal fatty acid-binding protein types, Histochem Cell Biol, 132, 351, 10.1007/s00418-009-0608-y Goudriaan, 2002, Intestinal lipid absorption is not affected affected in CD36 deficient mice, Mol Cell Biochem, 239, 199, 10.1023/A:1020575412789 Cassidy, 1985, Lipid accumulation in jejunal and colonic mucosa following chronic cholestyramine (Questran) feeding, Dig Dis Sci, 30, 10.1007/BF01318181 Werner, 2006, Lymphatic chylomicron size is inversely related to biliary phospholipid secretion in mice, Am J Physiol Gastrointest Liver Physiol, 290, G1177, 10.1152/ajpgi.00127.2005 Tang, 2009, Mechanism of direct bicarbonate transport by the CFTR anion channel, J Cyst Fibros, 8, 115, 10.1016/j.jcf.2008.10.004 Kauer, 2004, Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas, Am J Physiol Gastrointest Liver Physiol, 287, G480, 10.1152/ajpgi.00035.2004 Hallberg, 2001, Gastric secretion in cystic fibrosis in relation to the migrating motor complex, Scand J Gastroenterol, 36, 121, 10.1080/003655201750065852 Gregory, 1996, Gastrointestinal pH, motility/transit and permeability in cystic fibrosis, J Pediatr Gastroenterol Nutr, 23, 513, 10.1097/00005176-199612000-00001 Garcia, 2009, Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion, J Clin Investig, 119, 2613, 10.1172/JCI38662 Quinton, 2010, Birth of mucus, Am J Physiol Lung Cell Mol Physiol, 298, L13, 10.1152/ajplung.00358.2009 Robinson, 1990, Duodenal pH in cystic fibrosis and its relationship to fat malabsorption, Dig Dis Sci, 35, 1299, 10.1007/BF01536423 Brady, 2006, An enteric-coated high-buffered pancreas lipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study, J Am Diet Assoc, 106, 1181, 10.1016/j.jada.2006.05.011 Kalnins, 2006, Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis, J Pediatr Gastroenterol Nutr, 42, 256, 10.1097/01.mpg.0000189356.93784.01 Jones, 2003, Drug therapies for reducing gastric acidity in people with cystic fibrosis, Cochrane Collab, 2, 1 Shindo, 1998, Omeprazole induces altered bile acid metabolism, Gut, 42, 266, 10.1136/gut.42.2.266 Weber, 1976, Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis, Gut, 17, 295, 10.1136/gut.17.4.295 O'Brien, 1993, Intestinal bile acid malabsorption in cystic fibrosis, Gut, 34, 1137, 10.1136/gut.34.8.1137 Fondacaro, 1982, Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect, Pediatr Res, 16, 494, 10.1203/00006450-198206000-00019 Roy, 1977, Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes, N Engl J Med, 297, 1301, 10.1056/NEJM197712152972401 Strandvik, 1996, Bile acid kinetics and biliary lipid composition in cystic fibrosis, J Hepatol, 25, 43, 10.1016/S0168-8278(96)80326-6 Regan, 1979, Reduced intraluminal bile acid concentrations and fat maldigestino in pancreatic insufficiency: correction by treatment, Gastroenterology, 77, 285, 10.1016/0016-5085(79)90278-6 Krag, 1974, Active and passive bile acids absorption in man, J Clin Investig, 53, 1686, 10.1172/JCI107720 Hepner, 1973, Metabolism of steroid and amino acid moieties of conjugated bile acids in man. III Cholyltaurine (taurocholic acid), J Clin Investig, 52, 433, 10.1172/JCI107200 Belli, 1987, Taurine improves the absorption of a fat meal in patients with cystic fibrosis, Pediatrics, 80, 517, 10.1542/peds.80.4.517 Darling, 1985, Effect of taurine supplements on fat absorption in cystic fibrosis, Pediatr Res, 19, 578, 10.1203/00006450-198506000-00015 Smith, 1991, Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial, Am J Dis Child, 145, 1401, 10.1001/archpedi.1991.02160120069022 Colombo, 1988, Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis, Scand J Gastroenterol, 23, 151, 10.3109/00365528809090237 De Curtis, 1992, Effect of taurine supplementation on fat and energy absorption in cystic fibrosis, Arch Dis Child, 67, 1082, 10.1136/adc.67.9.1082 Merli, 1994, Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial, J Pediatr Gastroenterol Nutr, 19, 198, 10.1097/00005176-199408000-00010 Thompson, 1987, Taurine supplementation, fat absorption, and growth in cystic fibrosis, J Pediatr, 111, 501, 10.1016/S0022-3476(87)80108-7 van Elburg, 1996, Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis, Pediatr Res, 39, 985, 10.1203/00006450-199606000-00010 Lewindon, 1998, Bowel dysfunction in cystic fibrosis: importance of breath testing, J Paediatr Child Health, 34, 79, 10.1046/j.1440-1754.1998.00159.x Lisowska, 2009, Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection, Acta Biochim Pol, 56, 631 Bruzzese, 2004, Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration, Aliment Pharmacol Ther, 20, 813, 10.1111/j.1365-2036.2004.02174.x Raia, 2000, Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients, Pediatr Res, 47, 344, 10.1203/00006450-200003000-00010 Sbarbati, 1998, Ultrastructural lesions in the small bowel of patients with cystic fibrosis, Pediatr Res, 43, 234, 10.1203/00006450-199802000-00013 Smyth, 2000, Intestinal inflammation in cystic fibrosis, Arch Dis Child, 82, 394, 10.1136/adc.82.5.394 Quigley, 2006, Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics and probiotics, Gastroenterology, 130, S78, 10.1053/j.gastro.2005.11.046 Martin, 2007, A top–down systems biology view of microbiome mammalian metabolic interactions in a mouse model, Mol Syst Biol, 112, 1 De Lisle, 2006, Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation, J Pediatr Gastroenterol Nutr, 42, 46, 10.1097/01.mpg.0000189322.34582.3e Norkina, 2004, Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine, Infect Immun, 72, 6040, 10.1128/IAI.72.10.6040-6049.2004 De Lisle, 2007, Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine, Am J Physiol Gastrointest Liver Physiol, 293, G577, 10.1152/ajpgi.00195.2007 Perdigon, 2001, Lactic acid bacteria and their effect on the immune stystem, Curr Issues Intest Microbiol, 1, 27 Martin, 2008, Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized micrbiome mouse model, Mol Syst Biol, 157, 1 Dalzell, 1990, Small intestinal permeability and orocaecal transit time in cystic fibrosis, Arch Dis Child, 65, 585, 10.1136/adc.65.6.585 Bali, 1983, Prolonged small-intestinal transit time in cystic fibrosis, Br Med J, 287, 1011, 10.1136/bmj.287.6398.1011 De Lisle, 2010, Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine, Neurogastroenterol Motil, 22, 10.1111/j.1365-2982.2009.01418.x Citters van, 2006, Ileal brake: neuropeptidergic control of intestinal transit, Curr Gastroenterol Rep, 8, 367, 10.1007/s11894-006-0021-9 De Lisle, 2007, Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine, Am J Physiol Gastrointest Liver Physiol, 293, G104, 10.1152/ajpgi.00548.2006 Freedman, 2004, Association of cystic fibrosis with abnormalities in fatty acid metabolism, N Engl J Med, 350, 560, 10.1056/NEJMoa021218 Jumpsen, 2006, Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis, J Cyst Fibros, 5, 77, 10.1016/j.jcf.2006.01.004 Andersson, 2008, Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid compostion and metabolism, J Lipid Res, 49, 1692, 10.1194/jlr.M700388-JLR200 Strandvik, 2010, Fatty acid metabolism in cystic fibrosis, Prostaglandins Leukot Essent Fatty Acids, 7, 1 Levy, 1992, Intraluminal and intracellular phases of fat absorption are impaired in essential fatty acid deficiency, Am J Physiol, 262, G319 Rogiers, 1984, Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients, Pediatr Res, 18, 704, 10.1203/00006450-198408000-00005 Maqbool, 2008, Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis, J Pediatr Gastroenterol Nutr, 47, 635, 10.1097/MPG.0b013e31817fb76b Werner, 2004, No indications for altered fatty acid metabolism in two murine models for cystic fibrosis, J Lipid Res, 45, 2277, 10.1194/jlr.M400238-JLR200 Freedman, 1999, A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(−/−) mice, Proc Natl Acad Sci USA, 96, 13995, 10.1073/pnas.96.24.13995 Snipes, 1968, The effects of essential fatty acid deficiency on the ultrastructure and functional capacity of the jejunal epithelium, Lab Investig, 18, 179 Peretti, 2005, Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients, Am J Physiol Gastrointest Liver Physiol, 290, G609, 10.1152/ajpgi.00332.2005 Korotkova, 2000, Essential fatty acid deficiency affects the fatty acid composition of the rat small intestinal and colonic mucosa differently, Biochim Biophys Acta, 1487, 319, 10.1016/S1388-1981(00)00121-9 Mailhot, 2009, CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells, Am J Physiol Gastrointest Liver Physiol, 297, G1239, 10.1152/ajpgi.00206.2009 Mailhot, 2010, CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells, PLoS ONE, 5, e10446, 10.1371/journal.pone.0010446 De Lisle, 2008, Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine, J Pediatr Gastroenterol Nutr, 47, 406, 10.1097/MPG.0b013e31817e0f2c Shoff, 2006, Neonatal Screening Group. Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis, Pediatrics, 117, 391, 10.1542/peds.2004-2832 Roulet, 1997, Essential fatty acid deficiency in well nourished young cystic fibrosis patients, Eur J Pediatr, 156, 952, 10.1007/s004310050750 Van Biervliet, 2005, Docosahexaenoic acid trials in cystic fibrosis: a review of the rationale behind the clinical trials, J Cyst Fibros, 4, 27, 10.1016/j.jcf.2004.11.001 Steinkamp, 2000, Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients, J Pediatr Gastroenterol Nutr, 31, 418, 10.1097/00005176-200010000-00016 van Egmond, 1996, Effect of linoleic acid intake on growth of infants with cystic fibrosis, Am J Clin Nutr, 63, 746, 10.1093/ajcn/63.5.746 Coste, 2007, An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis, Clin Biochem, 40, 511, 10.1016/j.clinbiochem.2007.01.002